TCT 92: Twelve-Month Prognostic Impact of Acute Kidney Injury Following Impella-Supported High-Risk PCI

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Abiomed</li><li>Proctor of Evlolut valve - Medtronic</li></ul>